VivoSeq
Musculoskeletal

Femoral Neck Fracture

7

Pipeline Programs↗

2

Active Trials↗

4

Companies Involved↗

Femoral Neck Fracture is an early-stage landscape with 7 programs across 4 companies. The most active players are Amring, Fresenius Kabi Oncology Ltd., Alnylam Pharmaceuticals. 3 therapies are approved with 1 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

33/100

Pipeline Velocity

6/100

Mech. Concentration

33/100

Completion Rate

60/100

Attrition Rate

29/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

A

Amring

1 program

Phase 3F

Fresenius Kabi Oncology Ltd.

1 program

ApprovedAlnylam Pharmaceuticals logo

Alnylam Pharmaceuticals

1 program

ApprovedP

Purdue Pharma LP

1 program

Preclinical

Pipeline

Programs by Phase

Analysis

Trial Status

7

clinical trials

Completed3 · 43%
Recruiting2 · 29%
Terminated1 · 14%
Withdrawn1 · 14%

Clinical Trials

Trial Activity

7 trials

Efficacy and Safety of Retrograde Intraarticular Injection, Topical Soaking of Tranexamic Acid (TXA), or Placebo in Femoral Neck Fractured Patients Undergoing Cementless Bipolar Hemiarthroplasty
Recruiting·KKing Chulalongkorn Memorial Hospital·N/A·NCT06289478·75 enrolled
Musculoskeletal Adaptive Platform Trial (MAPT): Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)
Recruiting·UUniversity of Southern California·Preclinical·NCT07244211·600 enrolled
Perioperative Analgesia by Femoral Perineural Catheter for Femoral Neck Fracture - Study KTcol
Completed·UUniversity Hospital, Angers·Phase 4·NCT01052974·60 enrolled
Postoperative Analgesia With Local Infiltration After Femoral Neck Fracture
Completed·OOdense University Hospital·Phase 4·NCT00529425·50 enrolled
Development of Acetabular Erosion After Hemiarthroplasty: an Exploratory Retrospective Study
Completed·RRijnstate Hospital·N/A·NCT06096883·134 enrolled
Topical Application of Tranexamic Acid and Postoperative Blood Loss in Femoral Neck Fractures
Terminated·—·Phase 3·NCT01727843·15 enrolled
Practice Survey on Femoral Neck Fractures and the Incidence of Type of Anesthesia on Patient Outcome
Withdrawn·AAstes·N/A·NCT02198820

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)